Synthetic and immunological studies on the OCT4 immunodominant motif antigen-based anti-cancer vaccine
Objective: Cancer stem cell is one of the important causes of tumorigenesis as well as a drug target in the treatment of malignant tumor. However, at present, there is no immune vaccine targeting these cells. Octamer-binding transcription factor 4 (OCT4), a marker of embryonic stem cells and germ ce...
Main Authors: | Tingting Chen, Kan Liu, Jiangyao Xu, Tianying Zhan, Maixian Liu, Li Li, Zhiwen Yang, Shuping Yuan, Wenyi Zou, Guimiao Lin, Dennis A. Carson, Christina C. N. Wu, Xiaomei Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2020-02-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/1571 |
Similar Items
-
Antitumor effect and mechanism of FZD7 polypeptide vaccine
by: Zhongke Hua, et al.
Published: (2022-10-01) -
Intra-Tumoral Activation of Endosomal TLR Pathways Reveals a Distinct Role for TLR3 Agonist Dependent Type-1 Interferons in Shaping the Tumor Immune Microenvironment
by: Graham Thomas, et al.
Published: (2021-07-01) -
Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation
by: Floriane Auderset, et al.
Published: (2019-07-01) -
En face OCT
by: Andre Romano, et al.
Published: (2014-04-01) -
Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
by: Samik Chakraborty, et al.
Published: (2023-10-01)